# Thermo Fisher Scientific Inc.: Form 10-Q for the period ended Apr 1, 2017

- Company: [Thermo Fisher Scientific Inc.](/companies/tmo.md) (CIK 97745)
- Form: 10-Q
- Filed: 2017-05-05
- Accepted by EDGAR: May 5, 2017, 09:43 ET
- Period: 2017-04-01
- Accession: 0000097745-17-000023
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/97745/000009774517000023/tmoq1201710q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/97745/000009774517000023/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2017-04-01.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Cost of revenue | 3 months, 2017-01-01 to 2017-04-01 | $2.13bn | us-gaap:CostOfGoodsSold |
| Research and development | 3 months, 2017-01-01 to 2017-04-01 | $215.4m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months, 2017-01-01 to 2017-04-01 | $1.33bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months, 2017-01-01 to 2017-04-01 | $622.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2017-01-01 to 2017-04-01 | $135.4m | us-gaap:InterestExpense |
| Income tax | 3 months, 2017-01-01 to 2017-04-01 | −$48.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2017-01-01 to 2017-04-01 | $551.4m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months, 2017-01-01 to 2017-04-01 | $1.40 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2017-01-01 to 2017-04-01 | $1.41 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2017-01-01 to 2017-04-01 | 394,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months, 2017-01-01 to 2017-04-01 | $361.5m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months, 2017-01-01 to 2017-04-01 | $93.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months, 2017-01-01 to 2017-04-01 | $59.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months, 2017-01-01 to 2017-04-01 | $500.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2017-04-01 | $713.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2017-04-01 | $7.25bn | us-gaap:AssetsCurrent |
| Total assets | at 2017-04-01 | $46.21bn | us-gaap:Assets |
| Current liabilities | at 2017-04-01 | $5.30bn | us-gaap:LiabilitiesCurrent |
| Current portion of debt | at 2017-04-01 | $1.88bn | us-gaap:DebtCurrent |
| Shareholders' equity | at 2017-04-01 | $21.80bn | us-gaap:StockholdersEquity |
| Shares outstanding | at 2017-04-01 | 391,219,918 shares | dei:EntityCommonStockSharesOutstanding |

## Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/97745/000009774517000023/tmoq1201710q.htm

Filed May 5, 2017.
Source: SEC EDGAR, the filing index for accession 0000097745-17-000023. Last ingested by Listed: Nov 14, 2026, 12:05 ET. No prices; not investment advice.
